NKAIN2 functions as a novel tumor suppressor in prostate cancer

Author:

Mao Xueying1,Luo Fei23,Boyd Lara K.1,Zhou Bowei23,Zhang Yanling45,Stankiewicz Elzbieta1,Marzec Jacek1,Vasiljevic Natasa6,Yu Yongwei7,Feng Ninghan8,Xu Jia3,Lorincz Attila6,Jiang Yong3,Chelala Claude1,Ren Guoping4,Berney Daniel M1,Zhao Shan-Chao2,Lu Yong-Jie1

Affiliation:

1. Centre for Molecular Oncology, Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK

2. Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China

3. Key Laboratory of Proteomics of Guangdong Province and Key Laboratory of Transcriptomics and Proteomics of Human Diseases Supported by The Ministry of Education of China, Southern Medical University, Guangzhou, 510515, China

4. Department of Pathology, The First Affiliated Hospital, Zhejiang University Medical College, Hangzhou, 310009, China

5. Department of Gynecology and Obstetrics, Sir Run Run Shaw Hospital, Zhejiang University Medical College, Hangzhou, 310009, China

6. Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK

7. Department of Pathology, Changhai Hospital, The Second Military Medical University, Shanghai, 200433, China

8. Department of Urology, Wuxi Second People's Hospital, Nanjing Medical University, Wuxi, 214002, China

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3